99 123

Cited 0 times in

AC133 항원 양성 급성백혈병의 생물학적 특성

Other Titles
 Biological Characteristics of AC133 Antigen-Positive Acute Leukemia 
Authors
 김진석  ;  맹호영  ;  정준원  ;  이승태  ;  한지숙  ;  고윤웅  ;  민유홍 
Citation
 Korean Journal of Hematology (대한혈액학회지), Vol.37(3) : 177-190, 2002 
Journal Title
 Korean Journal of Hematology (대한혈액학회지) 
ISSN
 1125-0546 
Issue Date
2002
Keywords
AC133 antigen ; Acute leukemia ; Apoptosis
Abstract
Background : AC133 antigen is a cell surface antigen which is selectively expressed on hematopoietc stem and progenitor cells. It has been reported that AC133 antigen is expressed on the subsets of CD34+ acute leukemia, and occasionally on CD34-acute leukemia. We investigated the clinical and biological characteristics of AC133 antigen-positive acute leukemia. Method: Thirty-six adult acute leukemia patients were analyzed using a cut-off criterion of 20% or more gated leukemic blasts expressing the AC133 antigen for AC133+ leukemia. The biological characteristics focused on apoptosis were examined using multicolor flow cytometry and Western blot analysis. Results: AC133 antigen was expressed in 12 cases (33.3%). Eleven of 21 (52.4%) acute myelogenous leukemia (AML) patients and 1 of 15 (6.7%) acute lymphoblastic leukemia patients were positive for AC133 antigen, and the difference was significant. None of the clinical prognostic markers were singificantly different between AC133+ and AC133- AML. Median disease free and overall survival time were not significantly different between AC133+ and AC133- AML. The expression rate of CD34 was significantly higher in AC133+ AML patients compared to those of AC133- AML (P=0.045). Among the apoptosis-related proteins, the Fas expression on the leukemic blasts was higher in the AC133+ AML(P=0.048), but Fas ligand, Bcl-2, caspase-3 expression rates were not significantly different between AC133+ and AC133 -AML. The apoptosis rate was signigicantly lower in the Ara-C treated AC133 + AML (P=0.049), but the apoptosis rates to other apoptosis-inducing agents (dox-orubicin, TNF-α) were not different between AC133+ and AC133-AML cells. We thought that there were some associations between a trend toward higher caspase-3 expression rates and lower Ara-C induced apoptosis rates in the AC133+ AML. Conclusion : There was no significant correlation between AC133 antigen expression and various clinical characteristics of acute leukemia, but the AC133 antigen might provide different biological characteristics including apoptosis from other immature cell surface markers. However, to verify the prognostic usefulness of AC133 antigen and the basis of the biological characteristics of AC133 antigen-positive acute leukemia, further study is needed.
Files in This Item:
T200209930.pdf Download
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers
Yonsei Authors
Ko, Yun Woong(고윤웅)
Min, Yoo Hong(민유홍) ORCID logo https://orcid.org/0000-0001-8542-9583
Lee, Seung Tae(이승태)
Cheong, June-Won(정준원) ORCID logo https://orcid.org/0000-0002-1744-0921
Hahn, Jee Sook(한지숙)
URI
https://ir.ymlib.yonsei.ac.kr/handle/22282913/144460
사서에게 알리기
  feedback

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse